STAT

Biotech’s biggest unicorn is now worth $7.5 billion

The financing comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform the body's cells into drug factories.

Moderna Therapeutics, a multibillion-dollar biotech startup, is raising $500 million in a round that values the company at $7.5 billion, according to the data provider Pitchbook.

The financing, first reported by Bloomberg, comes as Moderna burns through about $450 million a year in an effort to craft medicines that can transform

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readSociety
Opinion: Don’t Let The Opioid Settlement Fritter Away Funds Like The Tobacco Settlement Did
Money from any forthcoming opioid settlement must be applied to help victims of opioid and other substance use disorders through access to evidence-based care, research, and training.
STAT6 min readSociety
Health Officials Are Hunting For The Culprit Behind Vaping-related Illnesses. Here Are Five Questions About The Outbreak
What’s causing it? And do all the cases represent the same illness? Those and other big, looming questions about the recent spate of vaping-related illnesses and deaths.
STAT6 min readSociety
Opinion: Ease Financial Toxicity By Putting Electronic Medical Records To Work
Clicking away on an electronic health record in the digital darkness of my exam room, I epitomize the moral injury of modern medicine as I systematically dispense doses of financial…